ALGT vs GSK · rev $943.5M vs P/E 13, $103.31B cap
Allegiant Travel Company (ALGT) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Allegiant Travel Company (ALGT) is a airlines company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported ALGT revenue for 2026-06-30 was $943.5M. Net income was -$4.9M. Revenue was up 28.8% from 2026-03-31 to 2026-06-30. ALGT currently screens at market cap $1.02B.
GSK does not have a complete income-statement cache yet.
ALGT currently screens at market cap $1.02B. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the ALGT and GSK stock pages for the full models.
Not investment advice.